Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial
about
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 yearsToward an exportable parent training program for disruptive behaviors in autism spectrum disorderBehavioral parent training to address sleep disturbances in young children with autism spectrum disorder: a pilot trialThe co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know?Exploring the manifestations of anxiety in children with autism spectrum disorders.Future directions for research on youth with bipolar spectrum disordersA Multisite Trial of Atomoxetine and Parent Training in Children with Autism Spectrum Disorders: Rationale and Design Challenges.New directions in the treatment of autism spectrum disorders from animal model research.Self-injurious behaviour in autistic children: a neuro-developmental theory of social and environmental isolation.Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problemsToward innovative, cost-effective, and systemic solutions to improve outcomes and well-being of military families affected by autism spectrum disorder.Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.Parent-child inpatient treatment for children with behavioural and emotional disorders: a multilevel analysis of within-subjects effects.Parent Training in Autism Spectrum Disorder: What's in a Name?Evolution of research on interventions for individuals with autism spectrum disorder: implications for behavior analysts.Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice.Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity DisorderReduced left precentral regional responses in patients with major depressive disorder and history of suicide attempts.A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder.Neural Mechanisms of Cognitive-Behavioral Therapy for Aggression in Children and Adolescents: Design of a Randomized Controlled Trial Within the National Institute for Mental Health Research Domain Criteria Construct of Frustrative Non-Reward.Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.Iron deficiency in pediatric patients in long-term risperidone treatmentPharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategiesPharmacotherapy for the core symptoms in autistic disorder: current status of the researchWeight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders.Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up.An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder.Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials.Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems.Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problemsChildren's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklistPsychotropic medications in autism: practical considerations for parents.Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorderTreatment of psychopathology in people with intellectual and other disabilities.Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.The use of antipsychotics in preschoolers: a veto or a sensible last option?Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder.Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.
P2860
Q22061984-6B6C0C38-1AD5-4EA2-8C1A-FCD8B6092E73Q24613892-93F4F52A-5461-4DEF-8659-3F8CDE01CECBQ30544948-BDD21D4C-B002-4910-A0D9-F055CFF25FB0Q33569253-FBCFC20B-7315-49C7-A186-93A6182B7EA1Q33684282-49CC69F1-BC94-4B91-83B7-3B45E4E193C7Q34063460-38FE926E-55D3-40AA-A26A-C5AA64BE6D52Q34130514-C0C8B361-C814-4B5F-B0DA-97DF6B96F3E8Q34267391-B145FB58-A9F6-49F4-AACB-36F0781F54FAQ34372746-45A329FC-C90A-4A8C-87FF-6711C39A9102Q34417629-FFEEB6B6-47F5-4B76-87D4-A14ACB7547E4Q35134497-45803C8F-B633-4983-9492-974D3D9F6AD0Q35757716-FBF7DCBC-4BAE-4F75-B39D-522056863F40Q35843128-D5ADD3A6-9D08-4939-9145-A66F6C047AA2Q35891994-70F885D6-9641-43BE-9B0E-3CF729B07D1CQ35986972-A04FCB18-181E-464B-BD92-DDEC9FFE0041Q36216477-68460C03-97BA-473D-8EA2-E34ADBF8A71CQ36221497-44C8FEDB-8D06-4C3C-881A-47A7347A4C74Q36336038-A9BECC30-8974-49CD-9C03-B84BDB7EE553Q36405769-08CD21E1-05BF-4D26-B305-9629B8B9C35AQ36654452-86200BCB-3C4B-483D-A692-59276269BC13Q36694513-2E37CE01-FB03-4D70-87C2-FED34EEE1079Q36720726-893DD74B-79DE-4B5B-A3D6-FF8CE0D8A001Q36740445-94CB2C8E-A3AA-4FD0-929C-0AED53F3960CQ36784208-AA7F595C-6CBB-4836-947D-9822B876BBB5Q36853567-CFA1EEA9-B217-421A-B6D4-B2AAA0884595Q36880820-28CB2C62-C6A3-4E4D-8A13-BB26CDD5F1E1Q36956632-93DC3B29-DE99-496B-8CD3-2B3F17795870Q37169671-E09DF3C9-3D56-4357-8747-74DAD767A8D0Q37409074-F82439A5-176F-4202-AC0D-D800CA046330Q37454964-78D1900E-C1A2-44E1-BCAB-C2D99437B660Q37547908-A0DB62A4-6777-4816-859D-93E7E0D0EF0FQ37616011-44614E68-B245-4A23-B250-37043EF04376Q37723279-CB4B4F64-E361-48AA-843B-EE130F2B7450Q37822304-3F14EDA9-A06F-4FFC-8047-592B03125327Q38017121-C9D9CA54-7B49-450F-A8B1-392269464628Q38052702-56C8E351-57B5-44B3-9E5A-6B404B1B7933Q38095762-8BBC320C-2D30-4256-BD48-AAB3C70E2AFFQ38180865-8EDBCF36-AAD6-4474-8841-DDDEE327FFEEQ38266796-B3D33831-54E3-4FFC-9502-1D398DE4FAB5Q38268023-67C6B4CE-0C58-4D39-B019-11D465F12B2F
P2860
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Medication and parent training ...... om a randomized clinical trial
@ast
Medication and parent training ...... om a randomized clinical trial
@en
type
label
Medication and parent training ...... om a randomized clinical trial
@ast
Medication and parent training ...... om a randomized clinical trial
@en
prefLabel
Medication and parent training ...... om a randomized clinical trial
@ast
Medication and parent training ...... om a randomized clinical trial
@en
P2093
P2860
P50
P1476
Medication and parent training ...... om a randomized clinical trial
@en
P2093
Allison Gavaletz
Ann Wagner
Arlene E Kohn
Benedetto Vitiello
Benjamin Handen
Cynthia Johnson
Eric Butter
James A Mulick
James Dziura
Jill A Hollway
P2860
P304
P356
10.1097/CHI.0B013E3181BFD669
P577
2009-12-01T00:00:00Z